A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Completed · Phase 4 · Has a placebo group

Conditions studied: Benign Prostatic Hyperplasia, Overactive Bladder

In brief

The purpose of the study was to assess the efficacy, safety, and tolerability of mirabegron versus placebo in men with overactive bladder (OAB) symptoms while taking tamsulosin hydrochloride for lower urinary tract symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH).

Key facts

Study ID
NCT02757768
Run by
Astellas Pharma Global Development, Inc.
People needed
715
Starts
2016-06-13
Expected to finish
2018-09-11
Last updated by the study team
2024-11-12

Who can join

Age: 40 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.